FORBES-TATE

Lobbying for GRAIL, INC. · Biotechnology Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 2

Health Issues

Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.

Medicare/Medicaid

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.